相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesis
Teng Gao et al.
NATURE COMMUNICATIONS (2021)
Identification of Immunological Parameters as Predictive Biomarkers of Relapse in Patients with Chronic Myeloid Leukemia on Treatment-Free Remission
Lorena Vigon et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Insights into clonal hematopoiesis and its relation to cancer risk
Shaneice R. Mitchell et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2021)
Somatic Mutations and the Risk of Undifferentiated Autoinflammatory Disease in MDS: An Under-Recognized but Prognostically Important Complication
Abdulla Watad et al.
FRONTIERS IN IMMUNOLOGY (2021)
PU.1 enforces quiescence and limits hematopoietic stem cell expansion during inflammatory stress
James S. Chavez et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Improving outcomes in chronic myeloid leukemia through harnessing the immunological landscape
Ya-Ching Hsieh et al.
LEUKEMIA (2021)
Factors affecting response to 5-azacytidine and prognosis of myelodysplastic syndrome. Is long-term survival a realistic goal?
Panagiotis T. Diamantopoulos et al.
LEUKEMIA RESEARCH (2021)
Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies
Anna Stengel et al.
BLOOD ADVANCES (2021)
Natural Killer Cell Subpopulations and Inhibitory Receptor Dynamics in Myelodysplastic Syndromes and Acute Myeloid Leukemia
Vlad Andrei Cianga et al.
FRONTIERS IN IMMUNOLOGY (2021)
Decitabine Promotes Modulation in Phenotype and Function of Monocytes and Macrophages That Drive Immune Response Regulation
Fabiana Albani Zambuzi et al.
CELLS (2021)
Exosomes as New Biomarkers and Drug Delivery Tools for the Prevention and Treatment of Various Diseases: Current Perspectives
Qi Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS
Jennifer J. Trowbridge et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Abnormal Macrophage Polarization in Patients with Myelodysplastic Syndrome
Gaochao Zhang et al.
MEDIATORS OF INFLAMMATION (2021)
Targeting of IL-10R on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells
Nianci Chen et al.
BLOOD CANCER JOURNAL (2021)
Macrophage-Regulatory T Cell Interactions Promote Type 2 Immune Homeostasis Through Resistin-Like Molecule α
Jiang Li et al.
FRONTIERS IN IMMUNOLOGY (2021)
Inflammatory Pathophysiology as a Contributor to Myeloproliferative Neoplasms
Daniel Arthur Corpuz Fisher et al.
FRONTIERS IN IMMUNOLOGY (2021)
The Prognostic Role of Cytogenetics Analysis in Philadelphia Negative Myeloproliferative Neoplasms
Giuseppe Lanzarone et al.
MEDICINA-LITHUANIA (2021)
Tissue regulatory T cells: regulatory chameleons
Andres R. Munoz-Rojas et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Altered immune response to the annual influenza A vaccine in patients with myeloproliferative neoplasms
Samah Alimam et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Macrophage frequency in the bone marrow correlates with morphologic subtype of myeloproliferative neoplasm
David C. A. Molitor et al.
ANNALS OF HEMATOLOGY (2021)
Influence of demethylation on regulatory T and Th17 cells in myelodysplastic syndrome
Xinyan Jia et al.
ONCOLOGY LETTERS (2020)
Regulatory T Cells and Human Disease
Shimon Sakaguchi et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
Flow cytometry and targeted immune transcriptomics identify distinct profiles in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors with or without interferon-α
Raquel Alves et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies
Mark P. Chao et al.
FRONTIERS IN ONCOLOGY (2020)
IL-6 blockade reverses bone marrow failure induced by human acute myeloid leukemia
Tian Yi Zhang et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Adaptive response to inflammation contributes to sustained myelopoiesis and confers a competitive advantage in myelodysplastic syndrome HSCs
Tomoya Muto et al.
NATURE IMMUNOLOGY (2020)
MYC-induced human acute myeloid leukemia requires a continuing IL-3/GM-CSF costimulus
Elizabeth Bulaeva et al.
BLOOD (2020)
PVR and ICAM-1 on Blast Crisis CML Stem and Progenitor Cells with TKI Resistance Confer Susceptibility to NK Cells
Nayoung Kim et al.
CANCERS (2020)
Overexpression of TIGIT in NK and T Cells Contributes to Tumor Immune Escape in Myelodysplastic Syndromes
Fanqiao Meng et al.
FRONTIERS IN ONCOLOGY (2020)
Clonal myelopoiesis in the UK Biobank cohort: ASXL1 mutations are strongly associated with smoking
Ahmed A. Z. Dawoud et al.
LEUKEMIA (2020)
Cancer therapy shapes the fitness landscape of clonal hematopoiesis
Kelly L. Bolton et al.
NATURE GENETICS (2020)
Increased Expression of TIGIT/CD57 in Peripheral Blood/Bone Marrow NK Cells in Patients with Chronic Myeloid Leukemia
Danlin Yao et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Emerging Role of Extracellular Vesicles in Immune Regulation and Cancer Progression
Sonam Mittal et al.
CANCERS (2020)
Bone marrow Tregs mediate stromal cell function and support hematopoiesis via IL-10
Virginia Camacho et al.
JCI INSIGHT (2020)
Tumor microenvironmental influences on dendritic cell and T cell function: A focus on clinically relevant immunologic and metabolic checkpoints
Kristian M. Hargadon
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
Tet2-mediated clonal hematopoiesis in nonconditioned mice accelerates age-associated cardiac dysfunction
Ying Wang et al.
JCI INSIGHT (2020)
Loss-of-function polymorphism in IL6R reduces risk of JAK2V617F somatic mutation and myeloproliferative neoplasm: A Mendelian randomization study
Kasper Monsted Pedersen et al.
ECLINICALMEDICINE (2020)
Regulatory T cells in cancer immunosuppression - implications for anticancer therapy
Yosuke Togashi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Role of natural killer cells for immunotherapy in chronic myeloid leukemia
Hye-Rim Lee et al.
ONCOLOGY REPORTS (2019)
A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia
Rosa Nguyen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
IL-6 and IL-8 secreted by tumour cells impair the function of NK cells via the STAT3 pathway in oesophageal squamous cell carcinoma
Jian Wu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Biological implications of clonal hematopoiesis
Tiago C. Luis et al.
EXPERIMENTAL HEMATOLOGY (2019)
Clonal hematopoiesis in human aging and disease
Siddhartha Jaiswal et al.
SCIENCE (2019)
Single-cell transcriptomics of human T cells reveals tissue and activation signatures in health and disease
Peter A. Szabo et al.
NATURE COMMUNICATIONS (2019)
Immunotherapy in acute myeloid leukemia and myelodysplastic syndromes: The dawn of a new era?
Yuxin Liu et al.
BLOOD REVIEWS (2019)
Inflammatory cytokines promote clonal hematopoiesis with specific mutations in ulcerative colitis patients
Christine R. C. Zhang et al.
EXPERIMENTAL HEMATOLOGY (2019)
First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia
Sarah Cooley et al.
BLOOD ADVANCES (2019)
Defective negative regulation of Toll-like receptor signaling leads to excessive TNF-α in myeloproliferative neoplasm
Hew Yeng Lai et al.
BLOOD ADVANCES (2019)
Dendritic cell subsets in T cell programming: location dictates function
S. C. Eisenbarth
NATURE REVIEWS IMMUNOLOGY (2019)
Benefits and pitfalls of pegylated interferon-α2a therapy in patients with myeloproliferative neoplasm-associated myelofibrosis: a French Intergroup of Myeloproliferative neoplasms (FIM) study
Jean-Christophe Ianotto et al.
HAEMATOLOGICA (2018)
Benefits and pitfalls of pegylated interferon-α2a therapy in patients with myeloproliferative neoplasm-associated myelofibrosis: a French Intergroup of Myeloproliferative neoplasms (FIM) study
Jean-Christophe Ianotto et al.
HAEMATOLOGICA (2018)
Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies
Robert L. Bowman et al.
CELL STEM CELL (2018)
Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML
Oscar Bruck et al.
LEUKEMIA (2018)
Characteristics of NK cells from leukemic microenvironment in MLL-AF9 induced acute myeloid leukemia
Feifei Yang et al.
MOLECULAR IMMUNOLOGY (2018)
Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option
Hauke Stamm et al.
ONCOGENE (2018)
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
Gang Chen et al.
NATURE (2018)
An introduction to immunology and immunopathology
Jean S. Marshall et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2018)
Cytokine Syntheses by T-Cell Subsets From Chronic Myeloid Leukemia Patients: Relationship Between Pre-Treatment Levels and Response to Imatinib Therapy
Inaam B. Hassan et al.
JOURNAL OF HEMATOLOGY (2018)
Chronic immune response dysregulation in MDS pathogenesis
Laura Barreyro et al.
BLOOD (2018)
Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia
M. Ilander et al.
LEUKEMIA (2017)
Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study
Delphine Rea et al.
HAEMATOLOGICA (2017)
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
S. Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Interferon γ is a STAT1-dependent direct inducer of BCL6 expression in imatinib-treated chronic myeloid leukemia cells
H. S. Madapura et al.
ONCOGENE (2017)
Immunological effects of hypomethylating agents
Katherine E. Lindblad et al.
EXPERT REVIEW OF HEMATOLOGY (2017)
Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia
Alyssa Carey et al.
CELL REPORTS (2017)
Down regulation of macrophage IFNGR1 exacerbates systemic L. monocytogenes infection
Emily M. Eshleman et al.
PLOS PATHOGENS (2017)
Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study
Delphine Rea et al.
HAEMATOLOGICA (2017)
Age-Related Macular Degeneration in Patients With Chronic Myeloproliferative Neoplasms
Marie Bak et al.
JAMA OPHTHALMOLOGY (2017)
Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia
Anne-Sophie Chretien et al.
FRONTIERS IN IMMUNOLOGY (2017)
The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells
Isabel Goncalves Silva et al.
EBIOMEDICINE (2017)
Interleukin-1β as emerging therapeutic target in hematological malignancies and potentially in their complications
Lorena Arranz et al.
BLOOD REVIEWS (2017)
IL-6/Stat3-Dependent Induction of a Distinct, Obesity-Associated NK Cell Subpopulation Deteriorates Energy and Glucose Homeostasis
Sebastian Theurich et al.
CELL METABOLISM (2017)
Inhibition of interleukin-1 signaling enhances elimination of tyrosine kinase inhibitor-treated CML stem cells
Bin Zhang et al.
BLOOD (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
MicroRNA-29b mediates altered innate immune development in acute leukemia
Bethany L. Mundy-Bosse et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Massive parallel RNA sequencing of highly purified mesenchymal elements in low-risk MDS reveals tissue-context-dependent activation of inflammatory programs
S. Chen et al.
LEUKEMIA (2016)
Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal
Eric M. Pietras et al.
NATURE CELL BIOLOGY (2016)
Increased IL-6 secretion by aged human mesenchymal stromal cells disrupts hematopoietic stem and progenitor cells' homeostasis
Kelsey O'Hagan-Wong et al.
ONCOTARGET (2016)
Assessment of the Number and Phenotype of Macrophages in the Human BMB Samples of CML
Jian-Xin Song et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Treatment of Chronic Myelogenous Leukemia by Blocking Cytokine Alterations Found in Normal Stem and Progenitor Cells
Robert S. Welner et al.
CANCER CELL (2015)
Comparative long-term effects of interferon α and hydroxyurea on human hematopoietic progenitor cells
Katherine Y. King et al.
EXPERIMENTAL HEMATOLOGY (2015)
G-CSF and GM-CSF in Neutropenia
Hrishikesh M. Mehta et al.
JOURNAL OF IMMUNOLOGY (2015)
The cytokine-mediated crosstalk between primary human acute myeloid cells and mesenchymal stem cells alters the local cytokine network and the global gene expression profile of the mesenchymal cells
Hakon Reikvam et al.
STEM CELL RESEARCH (2015)
Functional and Phenotypic Plasticity of CD4+ T Cell Subsets
Tiffany Caza et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Expansion of circulating CD56bright natural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α
Caroline H. Riley et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2015)
Type I interferons in infectious disease
Finlay McNab et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Acute myeloid leukemia impairs natural killer cells through the formation of a deficient cytotoxic immunological synapse
Zena Khaznadar et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Prognostic value of regulatory T cells in newly diagnosed chronic myeloid leukemia patients
Asmaa M. Zahran et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2014)
Co-inhibition of NF-κB and JNK is synergistic in TNF-expressing human AML
Andrew Volk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
IL-6 in Inflammation, Immunity, and Disease
Toshio Tanaka et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
Cytokine secretion in macrophages: SNAREs, Rabs, and membrane trafficking
Rachael Zoe Murray et al.
FRONTIERS IN IMMUNOLOGY (2014)
The Molecular Basis of IL-10 Function: from Receptor Structure to the Onset of Signaling
Mark R. Walter
INTERLEUKIN-10 IN HEALTH AND DISEASE (2014)
Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia vera
Ann Mullally et al.
BLOOD (2013)
A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency
Benedicte Neven et al.
BLOOD (2013)
Epigenetic Roles of MLL Oncoproteins Are Dependent on NF-κB
Hsu-Ping Kuo et al.
CANCER CELL (2013)
Immune evasion in acute myeloid leukemia: current concepts and future directions
Ryan M. Teague et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2013)
The integration of T cell migration, differentiation and function
David Masopust et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Epigenetic alterations in hematopoietic malignancies
Young Rock Chung et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2012)
NK cells are dysfunctional in human chronic myelogenous leukemia before and on imatinib treatment and in BCR-ABL-positive mice
Ci-U Chen et al.
LEUKEMIA (2012)
Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands
Stephan Munich et al.
ONCOIMMUNOLOGY (2012)
IL-6 Controls Leukemic Multipotent Progenitor Cell Fate and Contributes to Chronic Myelogenous Leukemia Development
Damien Reynaud et al.
CANCER CELL (2011)
Th17 and Foxp3+ T regulatory cell dynamics and distribution in myelodysplastic syndromes
Irene Bouchliou et al.
CLINICAL IMMUNOLOGY (2011)
Targeting Immune Dysregulation in Myelodysplastic Syndromes
Matthew J. Olnes et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Chronic Immune Stimulation Might Act As a Trigger for the Development of Acute Myeloid Leukemia or Myelodysplastic Syndromes
Sigurdur Y. Kristinsson et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche
Andrew Chow et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
The Four types of Tregs in malignant lymphomas
Jing Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2011)
Frequent pathway mutations of splicing machinery in myelodysplasia
Kenichi Yoshida et al.
NATURE (2011)
Further activation of FLT3 mutants by FLT3 ligand
R. Zheng et al.
ONCOGENE (2011)
Inflammatory signals regulate hematopoietic stem cells
Megan T. Baldridge et al.
TRENDS IN IMMUNOLOGY (2011)
Severe congenital neutropenia, a genetically heterogeneous disease group with an increased risk of AML/MDS
Peter Vandenberghe et al.
PEDIATRIC REPORTS (2011)
The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation
Pedro Farinha et al.
BLOOD (2010)
Mono/oligoclonal T and NK cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy
Anna Kreutzman et al.
BLOOD (2010)
Single nucleotide polymorphisms in the human TNF gene are associated with anaemia and neutropenia in a cohort of patients with de novo myelodysplastic syndrome
Aric Parnes et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Distinct Clinical Phenotypes Associated with JAK2V617F Reflect Differential STAT1 Signaling
Edwin Chen et al.
CANCER CELL (2010)
Biological characteristics of myelodysplastic syndrome patients who demonstrated high versus no intramedullary apoptosis
Saleem Dar et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Naturally occurring CD4+ CD25+ FOXP3+ T-regulatory cells are increased in chronic myeloid leukemia patients not in complete cytogenetic remission and can be immunosuppressive
Jose M. Rojas et al.
EXPERIMENTAL HEMATOLOGY (2010)
Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome
M. Carlsten et al.
LEUKEMIA (2010)
The regulation of IL-10 production by immune cells
Margarida Saraiva et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression
Sabine Mumprecht et al.
BLOOD (2009)
IL-17-producing CD4+ T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome
Shahram Y. Kordasti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Glucocorticoid-Induced Tumor Necrosis Factor Receptor-Related Protein Ligand Subverts Immunosurveillance of Acute Myeloid Leukemia in Humans
Tina Baessler et al.
CANCER RESEARCH (2009)
CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
Siddhartha Jaiswal et al.
CELL (2009)
High rates of durable response are achieved with imatinib after treatment with interferon α plus cytarabine: results from the International Randomized Study of Interferon and STI571 (IRIS) trial
Francois Guilhot et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Dendritic cells and cytokines in human inflammatory and autoimmune diseases
Patrick Blanco et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function
A. Mario Marcondes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome
Daniella B. Kerbauy et al.
EXPERIMENTAL HEMATOLOGY (2007)
CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS)
Shahram Y. Kordasti et al.
BLOOD (2007)
High molecular response rate of polycythemia vera patients treated with pegylated interferon α-2a
Jean-Jacques Kiladjian et al.
BLOOD (2006)
The role of leukemia-derived B7-H1 (PD-L1) in tumor-T-cell interactions in humans
Helmut Rainer Salih et al.
EXPERIMENTAL HEMATOLOGY (2006)
Tumor growth impedes natural-killer-cell maturation in the bone marrow
John O. Richards et al.
BLOOD (2006)
Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome
EM Sloand et al.
BLOOD (2005)
ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming
E Segura et al.
BLOOD (2005)
The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells
ML Guzman et al.
BLOOD (2005)
Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner
R Seggewiss et al.
BLOOD (2005)
Interferon-γ:: an overview of signals, mechanisms and functions
K Schroder et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Interleukin-1β maintains an apoptosis-resistant phenotype in the blast cells of acute myeloid leukaemia via multiple pathways
J Turzanski et al.
LEUKEMIA (2004)
Preferential induction of apoptosis for primary human leukemic stem cells
ML Guzman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias
OG Ottmann et al.
BLOOD (2002)
Signaling via the interferon-α receptor in chronic myelogenous leukemia cells
A Verma et al.
LEUKEMIA & LYMPHOMA (2002)
The p38 MAPK pathway mediates the growth inhibitory effects of interferon-α in BCR-ABL-expressing cells
IA Mayer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Role of CD47 as a marker of self on red blood cells
PA Oldenborg et al.
SCIENCE (2000)
分享论文
